Betulin-Containing Birch Bark Extracts and Their Formulation
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 16/959,098, filed Jun 29, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,083,733 | Betulin-Containing Birch Bark Extracts and Their Formulation In force · Medium confidence UsedRemaining | Amryt Pharmaceuticals Designated Activity Company | In force | Medium confidence | ||
| US 11,266,660 | Betulin-Containing Birch Bark Extracts and Their Formulation In force · Medium confidence | Amryt Pharmaceuticals Designated Activity Company | In force | Medium confidence | ||
| US 11,826,374 | Betulin-Containing Birch Bark Extracts and Their Formulation In force · Medium confidence | Amryt Pharmaceuticals Designated Activity Company | In force | Medium confidence | ||
| US 12,268,695 | Betulin-Containing Birch Bark Extracts and Their Formulation In force · Medium confidence | Amryt Pharmaceuticals Designated Activity Company | In force | Medium confidence | ||
| Application 16/959,098 | Betulin-Containing Birch Bark Extracts and Their Formulation Abandoned Abandoned Aug 9, 2023 | Amryt Pharmaceuticals Designated Activity Company | Abandoned | Abandoned Aug 9, 2023 | ||
| Application 19/068,545 | Betulin-Containing Birch Bark Extracts and Their Formulation Amyrt Pharmaceuticals Designated Activity Company Pending Not granted | Amyrt Pharmaceuticals Designated Activity Company | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Amryt Pharmaceuticals Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.